Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products!
Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CD7-M82E8 | Mouse | Biotinylated Mouse EMMPRIN / CD147 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
|
CD7-HF222 | Human | FITC-Labeled Human EMMPRIN / CD147 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H82E0 | Human | Biotinylated Human EMMPRIN / CD147 Protein, Avitag™,His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H5259 | Human | Human EMMPRIN / CD147 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H5222 | Human | Human EMMPRIN / CD147 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Biotinylated Human EMMPRIN, Avitag,His Tag (Cat. No. CD7-H82E0) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-EMMPRIN Antibody, Mouse IgG1 with a linear range of 0.1-4 ng/mL (QC tested).
The purity of Biotinylated Human EMMPRIN, His,Avitag (Cat. No. CD7-M82E8) is more than 85% and the molecular weight of this protein is around 28-42 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Iodine[131I] Metuximab | Approved | Chengdu Huasun Biotechnology Co Ltd | Licartin, 利卡汀 | Mainland China | Carcinoma, Hepatocellular | Chengdu Huasun Biotechnology Co Ltd | 2006-10-12 | Carcinoma, Hepatocellular | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Mertuzumab | Phase 3 Clinical | Jiangsu Pacific-Meinuoke Bio-Pharmaceutical Co Ltd, Institute Of Medicine Fourth Military Medical University | Coronavirus Disease 2019 (COVID-19); Carcinoma, Non-Small-Cell Lung | Details | |
Meplazumab | HI6H8 | Phase 3 Clinical | Jiangsu Pacific-Meinuoke Bio-Pharmaceutical Co Ltd, Institute Of Medicine Fourth Military Medical University | Malaria; Coronavirus Disease 2019 (COVID-19); Malaria, Falciparum | Details |
Anti-CD147 CAR T cell therapy (Xijing Hospital) | Phase 1 Clinical | The First Affiliated Hospital of Air Force Medical University | Glioblastoma | Details | |
CD147-CAR T cell therapy (Peking University People's Hospital) | Phase 1 Clinical | Peking University People'S Hospital | Lymphoma, T-Cell | Details | |
89Zr-CD147 | Phase 1 Clinical | Beijing Xiantong International Technology Co Ltd | Solid tumours | Details |
This web search service is supported by Google Inc.